Evidence map›Paper›PMID 26910760›Full record

ArticleGene therapy2016

β1-Na(+),K(+)-ATPase gene therapy upregulates tight junctions to rescue lipopolysaccharide-induced acute lung injury.

X Lin, M Barravecchia, P Kothari, J L Young, D A Dean

Abstract read
PubMed Publisher
In one paragraph

Article in Gene therapy, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 52 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Pulmonary gene delivery-Realities and possibilities.Experimental biology and medicine (Maywood, N.J.) · 2021
    Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

X LinDepartment of Pediatrics, School of Medicine and Dentistry, University of Rochester, Rochester, NY, USA.
M BarravecchiaDepartment of Pediatrics, School of Medicine and Dentistry, University of Rochester, Rochester, NY, USA.
P KothariDepartment of Pediatrics, School of Medicine and Dentistry, University of Rochester, Rochester, NY, USA.
J L YoungDepartment of Pediatrics, School of Medicine and Dentistry, University of Rochester, Rochester, NY, USA.
D A DeanDepartment of Pediatrics, School of Medicine and Dentistry, University of Rochester, Rochester, NY, USA.
University of Rochester · US

Funding

MULTIDISCIPLINARY TRAINING IN PULMONARY RESEARCHT32HL066988 · NHLBI · UNIVERSITY OF ROCHESTER · PI GEORAS, STEVE N, O'REILLY, MICHAEL A · 2001 to 2021
$8.1M
Electroporation-mediated Pulmonary Gene Transfer for Acute Lung InjuryR21HL092801 · NHLBI · UNIVERSITY OF ROCHESTER · PI DEAN, DAVID A · 2008 to 2012
$2.9M
MOLECULAR CLONING OF THE FRAGILE X SITER01HD020521 · NICHD · EMORY UNIVERSITY · PI WARREN, STEPHEN T. · 1986 to 2011
$2.8M
Alveolar Epithelial Cell-Specific Gene Therapy PlasmidsR01HL081148 · NHLBI · UNIVERSITY OF ROCHESTER · PI DEAN, DAVID A · 2006 to 2010
$1.8M
Cell-specific gene delivery methods for expression and silencing in the lungR01HL120521 · NHLBI · UNIVERSITY OF ROCHESTER · PI DEAN, DAVID A · 2014 to 2017
$1.5M
NHLBI NIH HHS R01 HL081148NHLBI NIH HHS R21 HL092801NHLBI NIH HHS T32 HL066988NICHD NIH HHS R01 HD020521
6 · The paper itself

Abstract

Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) are associated with diverse disorders and characterized by disruption of the alveolar-capillary barrier, leakage of edema fluid into the lung, and substantial inflammation leading to acute respiratory failure. Gene therapy is a potentially powerful approach to treat ALI/ARDS through repair of alveolar epithelial function. Herein, we show that delivery of a plasmid expressing β1-subunit of the Na(+),K(+)-ATPase (β1-Na(+),K(+)-ATPase) alone or in combination with epithelial sodium channel (ENaC) α1-subunit using electroporation not only protected from subsequent lipopolysaccharide (LPS)-mediated lung injury, but also treated injured lungs. However, transfer of α1-subunit of ENaC (α1-ENaC) alone only provided protection benefit rather than treatment benefit although alveolar fluid clearance had been remarkably enhanced. Gene transfer of β1-Na(+),K(+)-ATPase, but not α1-ENaC, not only enhanced expression of tight junction protein zona occludins-1 (ZO-1) and occludin both in cultured cells and in mouse lungs, but also reduced pre-existing increase of lung permeability in vivo. These results demonstrate that gene transfer of β1-Na(+),K(+)-ATPase upregulates tight junction formation and therefore treats lungs with existing injury, whereas delivery of α1-ENaC only maintains pre-existing tight junction but not for generation. This indicates that the restoration of epithelial/endothelial barrier function may provide better treatment of ALI/ARDS.

Indexed as

Acute Lung InjuryAnimalsDisease Models, AnimalElectroporationEpithelial Sodium ChannelsGenetic TherapyLipopolysaccharidesMaleMiceMice, Inbred C57BLPlasmidsRespiratory Distress SyndromeSodium-Potassium-Exchanging ATPaseTight JunctionsUp-RegulationEpithelial Sodium ChannelsLipopolysaccharidesSodium-Potassium-Exchanging ATPase

Identifiers

PMID26910760
OpenAlexW2326185270

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.